Advertisement

Intervening through Pharmacy Services

  • Ernest J. Dole

Abstract

The public, at least in the United States, has long held the pharmaceutical profession in high esteem and pharmacists are among the most accessible healthcare providers (Gallup News Service, 1997). Often the community utilizes the pharmacist as a reliable and available source of medical and pharmaceutical information. The profession of pharmacy has a covenant with society regarding safe and appropriate medication use. Pharmacists possess a unique knowledge base that brings together the pharmacology, pharmacokinetics, pharmacodynamics, toxicology, mechanism of action, adverse effects and interaction potential of pharmaceutical agents. Pharmacists then integrate this knowledge with an in-depth understanding of pathophysiology to improve patient care.

Keywords

Smoking Cessation Pharmaceutical Care Clinical Pharmacist Pharmacy Service Pharmacy Student 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. American Pharmaceutical Association. Official Policy of the American Pharmaceutical Association. Subject: Impaired Pharmacists. 1982.Google Scholar
  2. ASHP position statement on pharmaceutical care. Am J Hosp Pharm 1993;50:1720–1723 Kohn LT.Google Scholar
  3. Baldwin JN, Alexander JW, Dole EJ et al. American Society of Health-System Pharmacists. ASHP Statement on the Pharmacist’s Role in Substance Abuse Prevention, Education and Assistance.Am J Health-Syst Pharm.1998;55:1721–1724.Google Scholar
  4. Baldwin JN, Dole EJ, Levine PJ et al. Survey of pharmacy substance abuse course content.Am J Pharm Ed.1994;58:47S–52S.Google Scholar
  5. Baldwin JN, Light KE, Stock C et al. Curricular guidelines for pharmacy education: substance abuse and addictive disease.Am J Pharm Ed.1991;55:311–316.Google Scholar
  6. Berger BA. Readiness for change: improving treatment adherence. Glaxo-Wellcome Continuing Education. 1997;8.Google Scholar
  7. Berger BA. Motivational interviewing helps patients confront change. US Pharmacist 1999;24:88–95.Google Scholar
  8. Berger BA, Anderson-Harper HM, Kavookjian J. Patient empowerment. US Pharmacist 1997;12Google Scholar
  9. Berger BA, Braxton-Lloyd K, Suchanek-Hudmon K. The pharmacist’s role in smoking cessation. US Pharmacist 2001;26:57–64.Google Scholar
  10. Berger BA, Suchanek-Hudmon K. Readiness for change: implications for patient care. J Am Pharm Asso. 1997;may/june:321–8.Google Scholar
  11. Blakey SA, Hixson-Wallace JA. Clinical and economic effects of pharmacy services in a geriatric ambulatory clinic.Pharmacotherapy. 2000;20:1198–1203.PubMedCrossRefGoogle Scholar
  12. Bond CA, Raehl CL, Franke T. Clinical pharmacy services, pharmacist staffing, and drug costs in United States hospitals.Pharmacotherapy. 1999;19:1354–62.PubMedCrossRefGoogle Scholar
  13. Bond CA, Raehl CL, Franke T. Clinical pharmacy services, pharmacy staffing, and the total cost of care in United States hospitals.Pharmacotherapy. 2000;20:609–21.PubMedCrossRefGoogle Scholar
  14. Bond CA, Raehl CL, Franke T. Interrelationships among mortality rates, drug costs, total cost of care, and length of stay in United States hospitals: Summary and recommendations for clini- cal pharmacy services and staffing.Pharmacotherapy. 2001;21:129–41.PubMedCrossRefGoogle Scholar
  15. Bozovich M, Rubino C, Edmunds J. Effect of a clinical pharmacist-managed lipid clinic on achieving national cholesterol education program low density lipoprotein goals.Pharmacotherapy. 2000;20:1375–83.PubMedCrossRefGoogle Scholar
  16. Carmichael JM, O’Connell MB, Devine B, et al. Collaborative drug therapy management by pharmacists.Pharmacotherapy. 1997;17:1050–61.PubMedGoogle Scholar
  17. Carson JJ. Pharmacist-coordinated program to improve use of pharmacotherapies for reducing risk of coronary artery disease in low-income adults. Am J Health-Syst Pharm. 1999;56:2319–24.Google Scholar
  18. Carter BL, Barnette DJ, Chrischilles E, et al. Evaluation of hypertensive patients after care provided by community pharmacists in a rural setting.Pharmacotherapy. 1997;17:1274–85.PubMedGoogle Scholar
  19. Cassidy IB, Keith MR, Coffey EL, et al. Impact of pharmacist-operated general medicine chronic care refill clinics on practitioner time and quality of care.Ann Pharmacother. 1996;30:745–51.PubMedGoogle Scholar
  20. Coast-Senior EA, Kroner BA, Kelley CL, et al. Management of patients with type 2 diabetes by pharmacists in primary care clinics.Ann Pharmacother. 1998;32:636–41.PubMedCrossRefGoogle Scholar
  21. Cowper PA, Weinberger M, Hanlon JT, et al. The cost-effectiveness of a clinical pharmacist inter- vention among elderly outpatients.Pharmacotherapy. 1998;18:327–32.PubMedGoogle Scholar
  22. Dole EJ. Beyond pharmaceutical care.Am J Hosp Pharm.1994;51:2183–4.PubMedGoogle Scholar
  23. Dole EJ, Baldwin JN, Murawski MM et al. American Association of Colleges of Pharmacy Guidelines for the Development of Psychoactive Substance Use Disorder Policies for Colleges of Pharmacy.Am J Pharm Ed.1999;63:28S-34SGoogle Scholar
  24. Dole EJ, Gupchup GV. A review of the problems associated with screening instruments used for alcohol use disorders in the elderly.Consult Pharm.1999;14:294–9.Google Scholar
  25. Dole EJ, Tommasello AC. Recommendations for implementing effective substance abuse education in pharmacy practice. HRSA/AMERSA/SAMHSA/CSAT Federal Number: 222 978 919. 2001. In Press.Google Scholar
  26. Erickson CT. Pharmacists can now play a bigger role in reducing drug problems. Texas State Board of Pharmacy Newsletter. 2001;3:1–3.Google Scholar
  27. Foss MT, Schoch PH, Sintek CD. Efficient operation of a high-volume anticoagulation clinic. Am J Health-Syst Pharm. 1999;56:443–9.PubMedGoogle Scholar
  28. Gallup News Service. 1997. Honesty and ethics poll: Pharmacists strengthen their position as the most highly rated occupation. Gallup Organization Poll Releases; December 13, 1997. Princeton, NJ.Google Scholar
  29. Gattis WA, Hasselblad V, Whellan DJ, et al. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team.Arch Intern Med.1999;159:1939–45.PubMedCrossRefGoogle Scholar
  30. Gettman DA, Swanson KM, Miller WR. Brief interventions by pharmacists to understand and moti- vate change among veteran outpatients misusing alcohol.J Am Pharm Asso.1999;39:265. abstractGoogle Scholar
  31. Gettman DA Sosa PC, Dole EJ. Barriers and strategies for educating pharmacy students about detecting and managing substance abuse. Am J Pharm Ed 2000;64 (winter supplement):108S.Google Scholar
  32. Hammond RW, Dole EJ. The pharmacist clinician: prescriptive authority in New Mexico.JMCP.1996;2:594–6.Google Scholar
  33. Hanlon JT, Weinberger M, Samsa GP, et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy.Am J Med.1996;100:428–37.PubMedCrossRefGoogle Scholar
  34. Hanlon JT, Fillenbaum GG, Schmader KE, et al. Inappropriate drug use among community- dwelling elderly.Pharmacotherapy. 2000;20:575–82.PubMedCrossRefGoogle Scholar
  35. Heplar CD. Pharmacy as a clinical profession.Am J Hosp Pharm.1985;42:1298–1306.Google Scholar
  36. Heplar CD, Strand LM. Opportunities and responsibilities in pharmaceutical care.Am J Hops Pharm.1999;47:533–543.Google Scholar
  37. Hudmon KS, Prokhorov AV, Corelli RL, et al. Helping tobacco users to quit: Pharmacists’ counsel- ing role. Presented at: American Society for Preventive Oncology 24th Annual Meeting, March 5–7, 2000, Bethesda, MD. abstract.Google Scholar
  38. Jameson J, VanNoord G, Vanderwoud K. The impact of a pharmacotherapy consultation on the cost and outcome of medical therapy.J Fam Pract.1995;41:469–72.PubMedGoogle Scholar
  39. Koch KE. Trends in collaborative drug therapy management.Drug Benefit Trends. 2000;12:45–54.Google Scholar
  40. Lipton HL, Bird JA. The impact of clinical pharmacists’ consultations on geriatric patients’ com- pliance and medical care use: a randomized controlled trial.The Gerontologist. 1994;34:307–15.PubMedCrossRefGoogle Scholar
  41. Maddux MS, Dong BJ, Miller WA, et al. A vision of pharmacy’s future roles, responsibilities, and manpower needs in the United States.Pharmacotherapy. 2000;20:991–1020.CrossRefGoogle Scholar
  42. McElnay JC, Maquire RA, Drummond A, Hughes CM. Smoking cessation: the contribution of com- munity pharmacy.Dis Manage Health Outcomes. 2000;8(3):147–158.CrossRefGoogle Scholar
  43. McGhan WF, Smith MD. Pharmacoeconomic analysis of smoking-cessation interventions.Am J Health-Syst Pharm.1996;53:45–52.PubMedGoogle Scholar
  44. Mitrany D, Elder R. Collaborative pharmacy practice: an idea whose time has come.JMCP.1999;5:487–91.Google Scholar
  45. Murawski MM, Juergens JP. Analysis of longitudinal pharmacy student alcohol and drug use sur- vey data.Am J Pharm Educ.2001;65:20–29.Google Scholar
  46. Rupp MT, McCallian DJ, Sheth KK. Developing and marketing a community pharmacy-based asthma management program.JAPhA.1997;NS37:694–9.Google Scholar
  47. Sinclair HZ, Bond CM, Lennox AS, et al. Training pharmacists and pharmacy assistants in the stage-of-change model of smoking cessation: A randomized controlled trial in Scotland.Tob Control. 1998;7:253–261.PubMedCrossRefGoogle Scholar
  48. Smith ML, Barnette DJ, Maffeo C. Refill program using pharmacy student interns in a primary care clinic.Am J Health-Syst Pharm.2000;57:756–9.PubMedGoogle Scholar
  49. Smith MD, McGhan WF, Lauger G. Pharmacist counseling and outcomes of smoking cessation.Am Pharm.1995;NS35(8):20–9.Google Scholar
  50. Sorrento TA, Bonanza KC, Salisbury DW. Pharmaceutical services in a capitated geriatric care pro- gram.Am J Health-Syst Pharm.1996;53:2848–52.PubMedGoogle Scholar
  51. Suchanek-Hudmon K, Berger BA. Pharmacy applications of the Transtheoretical model in smok- ing cessation.Am J Health-Syst Pharm.1995;52:282–7.Google Scholar
  52. Suchanek-Hudmon K, Corelli RL, Berger BA. Treating tobacco use and dependence. RX consult- ant. 2001. In pressGoogle Scholar
  53. Suchanek-Hudmon K, Corelli RL, Kroon LA et al. Reducing pulmonary disease: the pharmacist’s role in smoking cessation.J Pharm Prac.2001;14:143–59.CrossRefGoogle Scholar
  54. To Err is Human: Building a Safer Health System. Washington, D.C., National Academy Press. 2000.Google Scholar
  55. Willcox SM, Himmelstein DU, Woolhandler S. Inappropriate drug prescribing for the community- dwelling elderly.JAMA.1994;272:292–96.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • Ernest J. Dole
    • 1
  1. 1.Department of Pharmaceutical CareLovelace Health SystemsAlbuquerqueUSA

Personalised recommendations